A pharmacogenetic study of escitalopram in autism spectrum disorders
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Objective: To determine the effect of serotonin transporter polymorphism promoter region (5‐HTTPLR) genotypic variation (low, intermediate, and high expression groups) on response to escitalopram treatment of children and adolescents with autism spectrum disorders (ASDs). Method: The study used a forced titration, open label design, with genotype blind until study completion. Participants were children and adolescents aged 4–17 years of age with a confirmed ASD (autistic disorder, Asperger's disorder, or pervasive developmental disorder, not otherwise specified). Results: There was an interaction between genotype group and time on the Aberrant Behavior Checklist (ABC) Irritability Subscale (primary outcome variable) (linear maximum marginal likelihood estimation=−4.84, Z=−2.89, SE=1.67, P=0.004). Examination of baseline to last visit revealed that a genotype grouping based on a previous study of platelet 5‐HT uptake revealed less response in the genotype group that had S/S genotype for 5‐HTTLPR and did not have a diplotype in intron 1 previously shown to be associated with increased platelet 5‐HT uptake. Conclusion: This genotype‐blind, prospective pharmacogenetic study found the group of subjects with associated with the lowest platelet 5‐HT uptake from previous study had the smallest reduction in ABC‐Irritability scores after open label treatment with escitalopram. Replication is necessary to confirm these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Combining Information From Multiple Sources in the Diagnosis of Autism Spectrum Disorders
RISI, S., LORD, C., GOTHAM, K., CORSELLO, C., CHRYSLER, C., SZATMARI, P., COOK, E. H., LEVENTHAL, B. L., & PICKLES, A. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000227880.42780.0e · Cited by 581 · cited 1×
“Therefore, these four participants all met the proposed ASD2 criteria proposed by Risi et al. [Risi et al., 2006].”
BackgroundSelf-citationKing, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., Donnelly, C. L., Anagnostou, E., Dukes, K., Sullivan, L., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.30 · Cited by 482
Clonidine Treatment of Hyperactive and Impulsive Children with Autistic Disorder
JASELSKIS, C. A., COOK, E. H., FLETCHER, K. E., & LEVENTHAL, B. L. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199210000-00005 · Cited by 328
Self-citationLast observation carried forward versus mixed models in the analysis of psychiatric clinical trials.
Hamer, R. M., & Simpson, P. M. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040458 · Cited by 233 · cited 1×
“…that subjects’ data do not vary after dropout and that the imputed LOCF data points are equal to the observed data, in addition to challenging the notion that LOCF is the most conservative approach [Hamer & Simpson, 2009; Lavori, Brown, Duan, Gibbons, & Greenhouse, 2008; Siddique et al., 2008].”
ResultMorning Light Treatment Hastens the Antidepressant Effect of Citalopram: A Placebo-Controlled Trial
Benedetti, F., Colombo, C., Pontiggia, A., Bernasconi, A., Florita, M., & Smeraldi, E. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0605 · Cited by 152 · cited 2×
“Some have suggested that there may be an association between 5-HTTPLR polymorphisms and response to multiple interventions; specifically, there is speculation that patients with the L/L genotype tend to have stronger expectancy responses to any treatment (for instance, in depression to light therapy, sleep deprivation…”
Background
Cited by
A Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders
McPheeters, M. L., Warren, Z., Sathe, N., Bruzek, J. L., Krishnaswami, S., Jerome, R. N., & Veenstra-VanderWeele, J. (2011) · Pediatrics · doi:10.1542/peds.2011-0427 · Cited by 356
Foss-Feig, J. H., Heacock, J. L., & Cascio, C. J. (2012) · Research in Autism Spectrum Disorders · doi:10.1016/j.rasd.2011.06.007 · Cited by 229
Demurie, E., Roeyers, H., Baeyens, D., & Sonuga‐Barke, E. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02374.x · Cited by 127
Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders
Francis, S. M., Sagar, A., Levin-Decanini, T., Liu, W., Carter, C. S., & Jacob, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.021 · Cited by 101
Probabilistic reinforcement learning in adults with autism spectrum disorders
Solomon, M., Smith, A. C., Frank, M. J., Ly, S., & Carter, C. S. (2011) · Autism Research · doi:10.1002/aur.177 · Cited by 97
Metadata
- Authors
- Owley, T., Brune, C. W., Salt, J., Walton, L., Guter, S., Ayuyao, N., Gibbons, R. D., Leventhal, B. L., & Cook, E. H.
- Venue
- Autism Research
- Publisher
- Wiley
- Published
- 2009-12-17
- Volume
- 3
- Issue
- 1
- Pages
- 1-7
- ISSN
- 1939-3792 (ISSN-L)
- 1939-3806
- OpenAlex
- W2045611038
- Cited by
- 72
- References
- 6
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A pharmacogenetic study of escitalopram in autism spectrum disorders. https://app.cochat.ai/papers/10.1002/aur.109
- The paper
- Owley, T., Brune, C. W., Salt, J., Walton, L., Guter, S., Ayuyao, N., Gibbons, R. D., Leventhal, B. L., & Cook, E. H. (2010). A pharmacogenetic study of escitalopram in autism spectrum disorders. Autism Research. https://doi.org/10.1002/aur.109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.